Pediatrix Medical Group, Inc.
DE ˙ DB ˙ US58502B1061
18,70 € ↑0,20 (1,08%)
2026-06-04
AKTIENPREIS
SecurityDE:PDC / Pediatrix Medical Group, Inc.
InstitutionLsv Asset Management
Latest Disclosed Ownership577,000 shares
Latest Disclosed Value $ 12,342
Lsv Asset Management reports 24.84% increase in ownership of PDC / Pediatrix Medical Group, Inc.

On May 11, 2026 - Lsv Asset Management filed a 13F-HR form disclosing ownership of 577,000 shares of Pediatrix Medical Group, Inc. (DE:PDC) valued at $10,386,000 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 462,200 shares of Pediatrix Medical Group, Inc.. This represents a change in shares of 24.84% during the quarter. The current value of the position is $10,789,900 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Pediatrix Medical Group COM 58502B106 577,000 114,800 24.84 12 33.33 0.0266
2026-02-06 2025-12-31 13F Pediatrix Medical Group COM 58502B106 462,200 156,400 51.14 10 80.00 0.0216
2025-11-06 2025-09-30 13F Pediatrix Medical Group COM 58502B106 305,800 7,496 2.51 5 25.00 0.0113
2025-08-11 2025-06-30 13F Pediatrix Medical Group COM 58502B106 298,304 50,304 20.28 4 33.33 0.0100
2025-05-09 2025-03-31 13F Pediatrix Medical Group COM 58502B106 248,000 213,700 623.03 4 0.0086
2025-02-13 2024-12-31 13F Pediatrix Medical Group COM 58502B106 34,300 -15,200 -30.71 0 0.0010
2024-11-12 2024-09-30 13F Pediatrix Medical Group COM 58502B106 49,500 0 0.00 1 0.0012
2024-08-06 2024-06-30 13F Pediatrix Medical Group COM 58502B106 49,500 0 0.00 0 0.0008
2024-05-06 2024-03-31 13F Pediatrix Medical Group COM 58502B106 49,500 0 0.00 0 0.0010
2024-02-06 2023-12-31 13F Pediatrix Medical Group COM 58502B106 49,500 25,800 108.86 0 0.0010
2023-11-03 2023-09-30 13F Pediatrix Medical Group COM 58502B106 23,700 0 0.00 0 0.0007
2023-08-02 2023-06-30 13F Pediatrix Medical Group COM 58502B106 23,700 0 0.00 0 0.0007
2023-05-02 2023-03-31 13F Pediatrix Medical Group COM 58502B106 23,700 23,700 0 0.0008
2021-08-04 2021-06-30 13F MEDNAX COM 58502B106 0 -966,489 -100.00 0 -100.00
2021-04-30 2021-03-31 13F MEDNAX COM 58502B106 966,489 -193,315 -16.67 24,616 -13.51 0.0421
2021-02-08 2020-12-31 13F MEDNAX COM 58502B106 1,159,804 -88,648 -7.10 28,461 40.04 0.0517
2020-10-23 2020-09-30 13F MEDNAX COM 58502B106 1,248,452 -4,200 -0.34 20,324 -5.12 0.0416
2020-08-05 2020-06-30 13F MEDNAX COM 58502B106 1,252,652 -33,900 -2.63 21,420 43.04 0.0444
2020-05-07 2020-03-31 13F MEDNAX COM 58502B106 1,286,552 -12,100 -0.93 14,975 -58.51 0.0362
2020-02-10 2019-12-31 13F Mednax COM 58502B106 1,298,652 183,857 16.49 36,089 43.12 0.0562
2019-11-07 2019-09-30 13F Mednax COM 58502B106 1,114,795 735,895 194.22 25,216 163.79 0.0417
2019-08-08 2019-06-30 13F/A-1 Mednax COM 58502B106 378,900 3,300 0.88 9,559 -6.33 0.0154
2019-08-07 2019-06-30 13F Mednax COM 58502B106 375,600 0 10,205
2019-05-07 2019-03-31 13F Mednax COM 58502B106 375,600 113,219 43.15 10,205 17.87 0.0163
2019-02-05 2018-12-31 13F Mednax COM 58502B106 262,381 217,281 481.78 8,658 311.50 0.0154
2018-11-06 2018-09-30 13F Mednax COM 58502B106 45,100 45,100 2,104 0.0031
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.